EndoGH™ is an endogenous GH therapy under developement by Pyxis Biologix, Inc. shown to significantly increase mean plasma GH and IGF-1 concentrations. This proprietary protein fragment prevents degradation, increases bioavailability, prolongs action of, enhances secretion of, and increases efficacy of growth hormone. It has been shown to improve weight loss, increase skeletal muscle and promote neurogenesis.